Ariceum Therapeutics Launches with €25M Series A
Find out what sets Ariceum Therapetutics apart within the radiopharmaceutical arena in this insightful interview with its CEO Manfred Rüdiger and Tyler Patchen of Endpoint News
Synklino’s Breakthrough Approach to Eliminate Transplant Related CMV
Synklino, the emerging biotech company developing breakthrough drugs for the treatment of chronic viral infections, accelerates development of its drug candidate SYN002 for the treatment of Cytomegalovirus (CMV), into both ex vivo and in vivo Phase 1 clinical trials, following a Series A fundraise of EUR 29.8 million. PKA pension fund led the funding round, […]
ON Helix Digital Conference 2022
Optimum supports One Nucleus’ flagship conference, ON Helix, which brings the network together to present and discuss the main innovation and technology trends in healthcare research and development. This one-day conference will address the main bio innovation trends, from the developments in life science and technology research to their translation into new diagnostics, prevention tools […]
Novo Ventures is ready for steady deployment of funds amid IPO lull
Novo Ventures senior partner, Naveed Siddiqi, discussed the opportunity in a slumbering IPO market to raise larger funding rounds, in an interview with Unquote.
A Q&A with ‘Rising Leader’ Therese Liechtenstein
Therese was selected as one of the top 30 Rising Leaders in the 3rd annual listing of In Vivo’s ‘Rising Leaders’ 2022.
